In many human cancers p53 expression is lost or a mutant p53 protein is expressed. Over the past 15 years it has become apparent that a large number of these mutant p53 proteins have lost wild type function, but more importantly have gained functions that promote tumorigenesis and drive chemo-resistance, invasion and metastasis. Many researchers have investigated the underlying mechanisms of these Gain-Of-Functions (GOFs) and it has become apparent that many of these functions are the result of mutant p53 hijacking other transcription factors. In this review, we summarize the latest research on p53 GOF and categorize these in light of the hallmarks of cancer as presented by Hannahan and Weinberg.
Skip Nav Destination
Review Article| April 11 2016
Novel targets and interaction partners of mutant p53 Gain-Of-Function
- Views Icon Views
- Share Icon Share
Lydia Aschauer, Patricia A.J. Muller; Novel targets and interaction partners of mutant p53 Gain-Of-Function. Biochem Soc Trans 15 April 2016; 44 (2): 460–466. doi: https://doi.org/10.1042/BST20150261
Download citation file: